COVID-19 vaccine trials abroad had been paused when adverse events were reported. This has not happened for Bharat Biotech’s COVAXIN trial following the death of a 45-year-old trial participant in Bhopal. The firm said the death of a COVAXIN trial participant is unrelated to the vaccine/placebo.
COVID-19 vaccine trials abroad had been paused when adverse events were reported. This has not happened for Bharat Biotech’s COVAXIN trial following the death of a 45-year-old trial participant in Bhopal. The firm said the death of a COVAXIN trial participant is unrelated to the vaccine/placebo.